Introduction: Severe asthma is a heterogenous disease with imprecise sub-classification into phenotypes based on clinical, functional or inflammatory parameters. Currently, there is a lack of information on overlapping and distinct characteristics of eosinophilic (EOS) and non-eosinophilic phenotypes in a global, real-life severe asthma cohort. This study aimed to describe and compare the baseline demographic and clinical characteristics between EOS and non-EOS phenotypes of severe asthma.
|Conference||Respiratory Effectiveness Group Summit 2020|
|Period||19/03/20 → 21/03/20|